14 Amorphous Solid Dispersions for Drug Product


Description:
Amorphous solid dispersions enabling formulations for drug product

Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Particle Technology Forum (03), Pharmaceuticals (15B)


Chair:
Justin D. Moser
Principal Scientist
Merck & Co., Inc.
Pharmaceutical Sciences
West Point, PA
19486
Email: justin_moser@merck.com

Co-Chair:
Anil Rane
Principal Scientist
Pfizer Gloabl Reseach and Development
CRD
Eastern point Rd
Groton, CT
06340
Email: anil.rane@pfizer.com


Papers:
14a
Sustained Supersaturation of Erlotinib Sdd Ternary Amorphous Systems
Kimberly B. Shepard, Capsugel Bend; Michael Morgen, Capsugel Bend
14b
Connecting the Product-Process-Performance Interplay for Improved Understanding in Development of a Spray Dried Dispersion Drug Product
Justin D. Moser, Merck & Co., Inc.; Jesse Kuiper, Merck Research Labs
14c
Strategically-Designed Polymer Synthons As Pharmaceutical Excipients in Oral Drug Delivery
Jeffrey Ting, University of Chicago; Swapnil Tale, University of Minnesota; Anatolii Purchel, University of Minnesota; Seamus D. Jones, University of Minnesota; Monica Ohnsorg, University of Minnesota; Soroush Moghadam, University of Michigan; Li Guo, The Dow Chemical Company; Steven Guillaudeu, The Dow Chemical Company; Ronald G. Larson, University of Michigan; Frank S. Bates, University of Minnesota; Theresa M. Reineke, University of Minnesota
14d
Pill Burden Reduction through Engineering the Mechanical Properties of Spray-Dried Amorphous Solid Dispersions
Alyssa Ekdahl, Capsugel; Aaron Goodwin, Capsugel; Deanna Mudie, Capsugel
14e
Reprocessing of Spray Dried Dispersions: Minimizing Resources in Process Development and Dealing with the Possible Failure
Tiago Porfirio, Instituto Superior Tecnico, University of Lisbon; Íris Duarte, Hovione FarmaCiência SA; Rui Ferreira, Hovione FarmaCiência SA; Bruno Henriques, Hovione FarmaCiência SA; João Vicente, Hovione FarmaCiência SA; Viriato Semião, Instituto Superior Tecnico, University of Lisbon
14f
In silico Development of Amorphous Solid Dispersions for Optimal Performance and Stability
Pedro Valente, Hovione FarmaCiência SA; Íris Duarte, Hovione FarmaCiência SA; Márcio Temtem, Hovione FarmaCiência SA
Abstract Submissions Closed
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum
<< Previous Session | Next Session >>